Evidence map›Paper›PMID 29577617›Full record

ArticleJournal of the International AIDS Society2018

A time-motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland.

Anton M Palma, Miriam Rabkin, Samkelo Simelane, Averie B Gachuhi, Margaret L McNairy, Harriet Nuwagaba-Biribonwoha, Pido Bongomin, Velephi N Okello, Raymond A Bitchong, Wafaa M El-Sadr

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Anton M PalmaICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.ORCID 0000-0003-1009-4701
Miriam RabkinICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.ORCID 0000-0002-2342-4362
Samkelo SimelaneICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
Averie B GachuhiICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
Margaret L McNairyICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
Harriet Nuwagaba-BiribonwohaICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.ORCID 0000-0001-5131-3371
Pido BongominICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
Velephi N OkelloSwaziland Ministry of Health, Mbabane, Swaziland.
Raymond A BitchongRaleigh Fitkin Memorial Hospital, Manzini, Swaziland.
Wafaa M El-SadrICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
ICAP Global HealthCornell University · USMemorial Hospital of South Bend · USMinistry of Health · SZ

Funding

Global HIV Implementation Science Research Training Grant RenewalT32AI114398 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yael R Hirsch-Moverman · 2014 to 2026
$4.1M
LINK4HEALTH: A Combination Strategy for Linkage and Retention, SwazilandR01AI100059 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EL-SADR, WAFAA M. · 2012 to 2014
$3.3M
NIAID NIH HHS R01 AI100059NIAID NIH HHS T32 AI114398
6 · The paper itself

Abstract

introductionScreening of modifiable cardiovascular disease (CVD) risk factors is recommended but not routinely provided for HIV-infected patients, especially in low-resource settings. Potential concerns include limited staff time and low patient acceptability, but little empirical data exists. As part of a pilot study of screening in a large urban HIV clinic in Swaziland, we conducted a time-motion study to assess the impact of screening on patient flow and HIV service delivery and exit interviews to assess patient acceptability.

methodsA convenience sample of patients ≥40 years of age attending routine HIV clinic visits was screened for hypertension, diabetes, hyperlipidemia and tobacco smoking. We observed HIV visits with and without screening and measured time spent on HIV and CVD risk factor screening activities. We compared screened and unscreened patients on total visit time and time spent receiving HIV services using Wilcoxon rank-sum tests. A separate convenience sample of screened patients participated in exit interviews to assess their satisfaction with screening.

resultsWe observed 172 patient visits (122 with CVD risk factor screening and 50 without). Screening increased total visit time from a median (range) of 4 minutes (2 to 11) to 15 minutes (9 to 30) (p < 0.01). Time spent on HIV care was not affected: 4 (2 to 10) versus 4 (2 to 11) (p = 0.57). We recruited 126 patients for exit interviews, all of whom indicated that they would recommend screening to others.

conclusionProvision of CVD risk factor screening more than tripled the length of routine HIV clinic visits but did not reduce the time spent on HIV services. Programme managers need to take longer visit duration into account in order to effectively integrate CVD risk factor screening and counselling into HIV programmes.

Indexed as

AdultAmbulatory CareCardiovascular DiseasesDelivery of Health Care, IntegratedEswatiniFemaleHIV InfectionsHumansMaleMiddle AgedPilot ProjectsRisk FactorsTime Factorscardiovascular diseaseHIVintegrationscreeningSwazilandtime-motion study

Identifiers

PMID29577617
PMCPMC5867276
OpenAlexW2796263844

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.